Blunt-tip ultra-thin wall microcannula for aesthetic injections
Certifications
CE Marked sterile single Use medical device for the European market.
Manufactured under ISO 13485–compliant quality management system.
Complies with relevant standards for disposable hypodermic needles and cannulas applicable in regions where marketed (e.g., ASTM/EN standards as declared by manufacturer).
CE Marked sterile single Use medical device for the European market.
Manufactured under ISO 13485–compliant quality management system.
Complies with relevant standards for disposable hypodermic needles and cannulas applicable in regions where marketed (e.g., ASTM/EN standards as declared by manufacturer).
Blunt-tip ultra-thin wall microcannula for aesthetic injections
Description
JBP Nanocannula 27G 40mm x 24 is an ultra-thin wall, flexible blunt-tip microcannula system designed for injectable aesthetic treatments. Engineered to minimise damage to hypodermal tissues, it features a smooth, micro-polished side port and a thin stainless-steel wall with a wide inner diameter, allowing low-resistance injection of dermal fillers, skin boosters, PRP and mesotherapy solutions. Compared with conventional sharp needles, the 27G x 40mm Nanocannula reduces pain, bruising, swelling and downtime while enabling precise product placement in sensitive facial areas. Each sterile, single-use cannula is supplied with a matching sharp punching needle, and boxes contain 24 cannulas. The range is CE-marked and manufactured under ISO 13485-compliant quality systems.
Bnefits
Reduces damage to hypodermal tissues thanks to flexible blunt-tip design and ultra-thin wall construction.
Less downtime and less internal bleeding compared with standard sharp needle injections.
Minimised pain and discomfort during treatment, improving patient experience.
Thin-walled cannula with wide inner diameter enables smoother injections with less resistance, even for more viscous fillers.
Micro-polished cannula hole produced with specialised nano technology for low-friction passage through tissue.
Blunt tip reduces the risk of accidental vascular penetration and associated complications.
Allows treatment of larger areas with fewer entry points, decreasing trauma and potential bruising.
Each set includes a dedicated punching (insertion) needle designed to minimise pain and surface trauma at the entry site.
CE-marked, ISO 13485–compliant device offering consistent quality and sterility.
Indications
Injection of dermal fillers (e.g., hyaluronic acid) for facial contouring and volumisation using cannula techniques.
Delivery of skin boosters and mesotherapy solutions for facial and body rejuvenation.
Administration of PRP and other regenerative injectables in aesthetic dermatology.
Fine-detail work and product placement in delicate facial areas such as lips, nasolabial folds, marionette lines, cheeks, jawline, temples and periocular/tear trough region where reduced bruising and swelling are desired.
Situations where a 27G gauge, 40 mm length cannula is appropriate for the planned tissue plane and injection technique.
Composition
Medical-grade stainless steel ultra-thin wall cannula shaft (27G, approximately 0.4 mm outer diameter) with wide internal lumen.
Blunt rounded cannula tip designed to reduce vascular and soft tissue trauma.
Micro-polished side port opening manufactured with nano/micron-level finishing technology.
Luer-lock compatible plastic hub, typically with alignment marking indicating the direction of the side port.
Matching sharp stainless-steel punching (insertion) needle included in each sterile unit.
Sterile blister packaging suitable for single-use EO or gamma-sterilised medical devices.
Formulation
Ultra-thin wall (UTW) blunt-tip microcannula with wide internal diameter relative to outer diameter for easier flow.
Gauge: 27G; length: 40 mm.
Designed for subdermal or other hypodermal injection planes depending on treatment indication and technique.
Single-use, sterile, CE-marked medical device intended for professional aesthetic and dermatologic procedures.
Optimised specifically for filler, mesotherapy and regenerative injectable delivery rather than general IV use.
Packaging
Standard configuration: 24 sterile, single-use cannulas (27G x 40 mm) per box.
Each cannula is individually blister-packed together with one corresponding sharp punching needle.
Outer box and individual blisters labelled with gauge, length, lot/batch number, expiry date, manufacturer/brand identification and CE mark.
Supplied as part of cannulae/needles/syringes ranges by aesthetic distributors such as Fillers Direct.
Usage
For professional use only; must be used by trained medical or aesthetic practitioners familiar with facial anatomy and cannula injection techniques.
Confirm that 27G x 40 mm is appropriate for the treatment area and the viscosity of the injectable product.
Maintain aseptic technique throughout; open the individual blister immediately before use, avoiding contact with the cannula shaft and tip.
Use the supplied sharp punching needle to create a small entry point in the skin at the selected site.
Insert the blunt-tip cannula through the entry point and advance gently along the intended tissue plane (e.g., subdermal or supraperiosteal) without excessive force.
Inject product slowly and evenly while withdrawing or moving the cannula (e.g., linear threading, retrograde injection, fanning) as determined by the chosen technique.
Follow current best-practice safety protocols for injectable fillers and mesotherapy, including appropriate aspiration or other risk-reduction steps where indicated.
After finishing the injections, withdraw the cannula, apply gentle pressure to the entry site as needed, and monitor the patient for immediate reactions.
Dispose of the used cannula and punching needle immediately in an approved sharps container. The device is strictly single-use and must not be resterilised or reused.
Contraindications
Patients with known hypersensitivity or allergy to stainless steel or any material used in the device.
Injection sites with active infection, inflammation, dermatitis, open wounds or compromised skin integrity.
Patients for whom injectable aesthetic procedures are contraindicated (e.g., certain autoimmune disorders, uncontrolled coagulation disorders, or use of specific anticoagulant therapies), as determined by the treating practitioner.
Use in or near major blood vessels where appropriate anatomical knowledge and precautions are not ensured.
Use if the sterile blister packaging is damaged, opened prior to intended use, or beyond the printed expiry date.
Reuse of any cannula or punching needle, or use of cannulas that are visibly bent or damaged.
Adverse Effects
Common injection-related reactions such as transient erythema, swelling, tenderness or mild discomfort at the entry point or along the cannula track.
Bruising or hematoma formation, although generally less frequent and less severe than with sharp needles.
Temporary edema, irregularities, or palpable tracks at the treatment area due to tissue manipulation or injected product.
Rare complications associated with injectable procedures, including infection, allergic reaction, and vascular occlusion or embolic events related to the injected product and technique.
Pain or unexpected tissue trauma if inappropriate technique, excessive force, or unsuitable gauge/length selection is used.
Storage Conditions
Store in a clean, dry environment at standard room temperature, away from direct sunlight and excessive heat or humidity.
Keep boxes and blisters intact and unopened until immediately before use to maintain sterility.
Avoid crushing, bending, or otherwise damaging the packaging that could deform cannulas.
Do not use cannulas that are past their expiry date or whose packaging shows signs of damage or moisture.
Duration
The cannula is used only during a single injection session. The duration of clinical effect is determined by the injected product (e.g., filler or mesotherapy solution) rather than the cannula itself.
Onset
Mechanical benefits such as reduced pain, bruising and tissue trauma are realised during and immediately after the procedure; aesthetic results follow the onset profile of the injected product.
